sábado, 17 de marzo de 2012

Analgesia, sedación y bloqueo neuromuscular en pacientes cardiacos mecánicamente ventilados


Analgesia, sedación y bloqueo neuromuscular en los pacientes cardiacos mecánicamente ventilados. Parte I: Analgesia
Analgesia, sedation and neuromuscular blockade in mechanically ventilated cardiac intensive care unit patients. Part I: Analgesia.
Vilela H, Ferreira D.
Serviço de Cardiologia, Hospital Fernando Fonseca Amadora, Portugal.
Rev Port Cardiol. 2006 Jan;25(1):89-98.
Abstract
This article reviews relevant clinical issues regarding sedation, analgesia and neuromuscular blockade in the cardiac intensive care unit, including monitoring tools and available therapeutic options. The pathophysiologic implications of pain, agitation, anxiety and delirium in the ventilated patient are also discussed. Although guidelines for sedation, analgesia and neuromuscular blocking drugs in critical carehave recently been published, there is great variability in clinical practice. The complexity of the environment and associated pathologies makes it difficult to implement universally applicable therapeutic regimens. Knowledge of pharmacologic mechanisms is an important tool in the development of dynamic protocols adapted to each unit. Strategies that include monitoring resources are essential for the optimization of sedation, analgesia and neuromuscular blockade.
http://www.spc.pt/DL/RPC/artigos/690.pdf
 
Analgesia, sedación y bloqueo neuromuscular en los pacientes cardiacos mecánicamente ventilados. Parte II. Sedación
Analgesia, sedation and neuromuscular blockade in mechanically ventilated cardiac intensive care unit patients. Part II Ssedation.
Vilela H, Ferreira D.
Serviço de Cardiologia, Hospital Fernando Fonseca, Amadora, Portugal.
Rev Port Cardiol. 2006 Feb;25(2):217-29.
Abstract
This article reviews relevant clinical issues regarding sedation, analgesia and neuromuscular blockade in the cardiac intensive care unit, including monitoring tools and available therapeutic options. The pathophysiologic implications of pain, agitation, anxiety and delirium in the ventilated patient are also discussed. Although guidelines for sedation, analgesia and neuromuscular blocking drugs in critical care have recently been published, there is great variability in clinical practice. The complexity of the environment and associated pathologies makes it difficult to implement universally applicable therapeutic regimens. Knowledge of pharmacologic mechanisms is an important tool in the development of dynamic protocols adapted to each unit. Strategies that include monitoring resources are essential for the optimization of sedation, analgesia and neuromuscular blockade.
http://www.spc.pt/DL/RPC/artigos/700.pdf
 
Analgesia, sedación y bloqueo neuromuscular en los pacientes cardiacos mecánicamente ventilados. Parte III. Bloqueo neuromuscular 
Analgesia, sedation and neuromuscular blockade in mechanically ventilated cardiac intensive care unit patients. Part III--Neuromuscular blockade.
Vilela H, Ferreira D.
Serviço de Cardiologia, Hospital Fernando Fonseca, Amadora, Portugal.
Rev Port Cardiol. 2006 Mar;25(3):341-50.
Abstract
This article reviews relevant clinical issues regarding sedation, analgesia and neuromuscular blockade in the cardiac intensive care unit, including monitoring tools and available therapeutic options. The pathophysiologic implications of pain, agitation, anxiety and delirium in the ventilated patient are also discussed. Although guidelines for sedation, analgesia and neuromuscularblocking drugs in critical care have recently been published, there is great variability in clinical practice. The complexity of the environment and associated pathologies makes it difficult to implement universally applicable therapeutic regimens. Knowledge of pharmacologic mechanisms is an important tool in the development of dynamic protocols adapted to each unit. Strategies that include monitoring resources are essential for the optimization of sedation, analgesia and neuromuscular blockade
http://www.spc.pt/DL/RPC/artigos/713.pdf
 
Atentamente
Anestesiología y Medicina del Dolor

24 DE MARZO DIA MUNDIAL DE LA TUBERCULOSIS


24 DE MARZO DIA MUNDIAL DE LA TUBERCULOSIS

MENSAJE DEL SECRETARIO GENERAL DE LA ONU

http://www.stoptb.org/assets/documents/news/tuberculosisday2012.Spanish.pdf

Dr. Isaías Orozco Andrade
Secretario Académico
Facultad de Medicina
Universidad Autónoma de Chihuahua

Jefe de la 
Clínica de Tuberculosis
Hospital Infantil del Estado de Chihuahua
Instituto Chihuahuense de Salud

Todos los artículos sobre farmacología pediátrica, a un clic